Mid-Market Corporate Buyout Equity · Private Equity, VC & Investor
Arsenal Capital Partners
Specialised private equity firm raising funds and acquiring portfolio companies.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Arsenal Capital Partners
- Entity type
- COMPANY
- Founded
- 2000
- Headquarters
- United States
- Company size
- 50–200
- Market cluster / sector
- Mid-Market Corporate Buyout Equity
- Market role
- Private Equity, VC & Investor
- Official website
- arsenalcapital.com
What Arsenal Capital Partners does
The firm pools capital from institutional limited partners into private equity funds, acquires controlling or influential stakes in target companies, and seeks to improve their value through strategic, operational, and transactional work before exiting through sale or recapitalisation. Value is created by combining sector specialisation, access to capital, deal sourcing, and portfolio management discipline.
Category differentiation
This is a private equity investment firm, not an advertising, software, or media operating company. It should also not be confused with businesses using the word 'Arsenal' in sports, media, or defence contexts.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Arsenal Capital Partners is a private equity firm based in the United States. The firm raises committed capital from institutional investors and deploys that capital into acquisitions, as evidenced by fund closes and portfolio transactions such as ATP Group and ThermoSafe. Its customers are primarily limited partners allocating capital to private equity funds, as well as portfolio companies that receive ownership, strategic oversight, and operational support. The business makes money through the standard private equity model: recurring management fees on committed or managed capital and performance-based carried interest on profitable exits. Arsenal positions itself as a specialised investor rather than an operating software, media, or advertising business.
Company news briefing
Briefing updated:
Arsenal Capital Partners has entered an agreement to acquire a majority stake in Velcro Companies, significantly expanding its industrial growth portfolio. To support this trajectory, the firm appointed Max Schechter as Head of Industrial Growth Business Development. Furthermore, a strategic partnership was established between Altasciences and Certara, demonstrating continued synergy within Arsenal’s healthcare and life sciences holdings. These developments illustrate a focused effort to bolster leadership and drive value across the firm’s core investment sectors.
Business model & monetisation
Arsenal primarily monetises via private equity fund economics: recurring management fees tied to committed or managed capital, plus carried interest from realised investment gains. Additional economics may arise from transaction-related and portfolio support arrangements, but the provided evidence most clearly supports a fund management and investment return model.
- Fund management fees
- Recurring fees on committed or managed capital
- Carried interest
- Performance share of realised investment gains
- Transaction and portfolio-related fees
- Deal execution or advisory economics
Products & capabilities
No products with linked sources are available in this view.
POLARIS7 WORKSPACE
Go deeper on Arsenal Capital Partners and its market context
Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.
- Corporate & subsidiary hierarchy
- Competitor & partner network
- Automated Watchlist briefings
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Arsenal Capital Partners's competitive landscape.
Partner-owned private equity firm investing institutional capital into businesses.
Private equity firm advising buyout funds and portfolio investments.
Private equity firm focused on acquisitions and operational value creation.
Private investment firm managing private markets funds and portfolio acquisitions.
Private investment firm backing growth-stage businesses.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Endpoint Clinical Acquires Bluefin
Product & Platform Launch · Recorded impact score: 4/5
Endpoint Clinical, a portfolio company of Arsenal Capital Partners, has acquired Bluefin, as announced in the news section.
Explore company relationships
Questions about Arsenal Capital Partners
What is Arsenal Capital Partners?
Arsenal Capital Partners is a US-based private equity firm that raises institutional capital and invests in portfolio companies through private equity funds.
Who uses Arsenal Capital Partners?
Its direct customers are institutional investors such as pension funds, insurers, foundations, and asset managers that commit capital to its funds.
How does Arsenal Capital Partners make money?
It earns recurring management fees on its funds and performance-based carried interest when portfolio investments are sold profitably.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
1 publicly documented primary sources and citations linked across the market graph.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Arsenal Capital Partners
Open extended company details, ownership links, and automated signal monitoring in Polaris7.
